Designing a novel ACE2 drug for the COVID-19 treatment

A research group led by Dr. Khalili (from Shahid Rajaee Teacher Training University) has designed a novel ACE2 drug for the COVID-19 treatment. The research of this study is accepted from the well-known journal “Journal of theoretical biology” as a leading forum for theoretical perspectives that give insight into biological processes. One can easily download this paper from the following link:

The results of this study can be considered for further evaluations in other research projects and hopefully in clinical applications.